HUE063661T2 - 3-(3,5-Diklór-4-hidroxibenzoil)-1,1-dioxo-2,3-dihidro-1,3-benzotiazol kristályos formája és sója - Google Patents
3-(3,5-Diklór-4-hidroxibenzoil)-1,1-dioxo-2,3-dihidro-1,3-benzotiazol kristályos formája és sójaInfo
- Publication number
- HUE063661T2 HUE063661T2 HUE18791567A HUE18791567A HUE063661T2 HU E063661 T2 HUE063661 T2 HU E063661T2 HU E18791567 A HUE18791567 A HU E18791567A HU E18791567 A HUE18791567 A HU E18791567A HU E063661 T2 HUE063661 T2 HU E063661T2
- Authority
- HU
- Hungary
- Prior art keywords
- hydroxybenzoyl
- benzothiazole
- dioxo
- dichloro
- dihydro
- Prior art date
Links
- VOFLAIHEELWYGO-UHFFFAOYSA-N (3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 VOFLAIHEELWYGO-UHFFFAOYSA-N 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017099334 | 2017-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE063661T2 true HUE063661T2 (hu) | 2024-01-28 |
Family
ID=63918527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18791567A HUE063661T2 (hu) | 2017-04-28 | 2018-04-27 | 3-(3,5-Diklór-4-hidroxibenzoil)-1,1-dioxo-2,3-dihidro-1,3-benzotiazol kristályos formája és sója |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10752601B2 (hu) |
| EP (1) | EP3617199B1 (hu) |
| JP (1) | JP7132211B2 (hu) |
| KR (1) | KR102597986B1 (hu) |
| CN (1) | CN110914246B (hu) |
| AU (1) | AU2018256993B9 (hu) |
| BR (1) | BR112019018840B1 (hu) |
| CA (1) | CA3055517A1 (hu) |
| ES (1) | ES2958064T3 (hu) |
| HR (1) | HRP20230829T1 (hu) |
| HU (1) | HUE063661T2 (hu) |
| IL (1) | IL269689B (hu) |
| MX (1) | MX2019010710A (hu) |
| MY (1) | MY185728A (hu) |
| PH (1) | PH12019501982A1 (hu) |
| PL (1) | PL3617199T3 (hu) |
| SG (1) | SG11201909747WA (hu) |
| TW (1) | TWI766986B (hu) |
| WO (1) | WO2018199277A1 (hu) |
| ZA (1) | ZA201905817B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3159300A1 (en) * | 2019-12-09 | 2021-06-17 | Tadashi Inoue | Solid pharmaceutical preparation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR051780A1 (es) | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
| US20080305169A1 (en) * | 2006-05-26 | 2008-12-11 | Japan Tobacco Inc. | Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds |
| US20080064871A1 (en) * | 2006-05-26 | 2008-03-13 | Japan Tobacco Inc. | Production Method of Nitrogen-Containing Fused Ring Compounds |
| GB0702458D0 (en) * | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
| JP2011507910A (ja) * | 2007-12-21 | 2011-03-10 | ユニバーシティー オブ ロチェスター | 真核生物の寿命を変更するための方法 |
| JP5325065B2 (ja) * | 2009-09-30 | 2013-10-23 | 株式会社富士薬品 | 新規フェノール誘導体 |
-
2018
- 2018-04-27 KR KR1020197031442A patent/KR102597986B1/ko active IP Right Grant
- 2018-04-27 HU HUE18791567A patent/HUE063661T2/hu unknown
- 2018-04-27 IL IL269689A patent/IL269689B/en unknown
- 2018-04-27 MY MYPI2019005045A patent/MY185728A/en unknown
- 2018-04-27 HR HRP20230829TT patent/HRP20230829T1/hr unknown
- 2018-04-27 JP JP2019514647A patent/JP7132211B2/ja active Active
- 2018-04-27 EP EP18791567.3A patent/EP3617199B1/en active Active
- 2018-04-27 US US16/482,149 patent/US10752601B2/en active Active
- 2018-04-27 CN CN201880027057.7A patent/CN110914246B/zh active Active
- 2018-04-27 SG SG11201909747W patent/SG11201909747WA/en unknown
- 2018-04-27 MX MX2019010710A patent/MX2019010710A/es unknown
- 2018-04-27 WO PCT/JP2018/017128 patent/WO2018199277A1/ja active Application Filing
- 2018-04-27 AU AU2018256993A patent/AU2018256993B9/en active Active
- 2018-04-27 CA CA3055517A patent/CA3055517A1/en active Pending
- 2018-04-27 PL PL18791567.3T patent/PL3617199T3/pl unknown
- 2018-04-27 BR BR112019018840-1A patent/BR112019018840B1/pt active IP Right Grant
- 2018-04-27 TW TW107114384A patent/TWI766986B/zh active
- 2018-04-27 ES ES18791567T patent/ES2958064T3/es active Active
-
2019
- 2019-08-29 PH PH12019501982A patent/PH12019501982A1/en unknown
- 2019-09-03 ZA ZA2019/05817A patent/ZA201905817B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202001340B (en) | Heterocyclic compound and use thereof | |
| HK1243348A1 (zh) | 作為免疫調節劑的3-取代的-1，2，4-噁二唑和噻二唑化合物 | |
| SG11201706908PA (en) | 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators | |
| LT3464284T (lt) | Mikrobiocidiniai tiazolo dariniai | |
| IL283486A (en) | Thiazole derivatives kill microorganisms | |
| IL274887B1 (en) | Thiazole derivatives kill microorganisms | |
| IL265298B (en) | History of 5-[2-(pyridin-2-ylamino)-3,1-thiazol-5-yl]-3,2,dihydro-1 h -isoindol-1-one and their use as dual inhibitors of phosphatidylinositol 3-kinase delta and gamma | |
| ZA201801089B (en) | N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides | |
| IL279939A (en) | History of thiadiazine | |
| IL273237A (en) | Novel heterocyclic compounds as MGLUR7 modulators | |
| IL272121A (en) | Preparation and methods for the treatment of myopia | |
| ZA201905817B (en) | Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole | |
| PL3694843T3 (pl) | Nowa sól i nowe stałe postacie escitalopramu | |
| EP3661505A4 (en) | BENZOTHIAZOLE AND RELATED COMPOUNDS | |
| ZA202002526B (en) | New alcoxyamino derivatives for treating pain and pain related conditions | |
| EP3568137A4 (en) | HETEROCYCLIC COMPOUNDS AND USE OF SUCH COMPOUNDS | |
| GB201707207D0 (en) | Treatment of type 1 diabetes | |
| LT3212644T (lt) | 2-(1,2,4-triazol-3-ilsulfanil)-n-1,3,4-tiadiazol-2-ilacetamido dariniai, kurie yra naudotini diabeto gydymui | |
| SG11201708692WA (en) | Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof | |
| IL271707A (en) | Heterocyclylmethylidine derivatives and their use as modulators of mGluR5 receptors | |
| HUP1700154A2 (en) | Use of nicosulfuron and clomazone on fabales/fabaceae | |
| IL246802B (en) | Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use |